Search clinical trials for: Zero-P

Total 6456 results

Jiangsu Province Centers for Disease Control and...
Wuhan Institute of Biological Products Co., Ltd

Completed

Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China

Hand, Foot and Mouth Disease

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated (COVID-19)

Covid19

China
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd; Hunan Provincial Center for Disease...

Not yet recruiting

Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19

China
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

COVID-19
Cancer Institute and Hospital, Chinese Academy...

Enrolling by invitation

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

COVID-19

Brazil, Malaysia
National Institute of Allergy and Infectious Diseases...

Completed

Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

Malaria

United States
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd; Hunan Provincial Center for Disease...

Not yet recruiting

Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
PT. Kimia Farma (Persero) Tbk

Active, not recruiting

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

COVID-19

Indonesia
Chulalongkorn University

Unknown

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Primary Immunodeficiency

Thailand
University of Manchester
Royal Children's Hospital

Completed

Triple P for Parents of Children With a Diagnosis of Cancer

Cancer

United Kingdom
Huashan Hospital

Completed

Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment

Central Nervous System Infections
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Rabies | Rabies Virus

China
Jiangsu Province Centers for Disease Control and...
Shandong Hengye Biotech Co., Ltd.

Completed

A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants

Encephalitis

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

COVID-19

China
Zhejiang Provincial Center for Disease Control...
Liaoning Chengda Biotechnology CO., LTD

Active, not recruiting

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Japanese Encephalitis | Vaccine Reaction | Vaccine Preventable Disease

China
Ology Bioservices

Completed

Yearly Strain Variation Study, 2010/2011

Influenza | Seasonal Influenza

Austria
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

COVID-19

Brazil
Abbott Medical Devices

Completed

ENHANCE-Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction (ENHANCE)

Bradycardia

Thailand, China, Australia, India, Italy
Fisher and Paykel Healthcare

Completed

The Evaluation of a Mask Seal/Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Coloplast A/S

Completed

Evaluation of the Peel Force of New Adhesives From the Skin

Stoma Ileostomy

Denmark
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemias
PT. Kimia Farma (Persero) Tbk

Recruiting

Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

COVID-19

Indonesia
ONY

No longer available

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

Neonatal Respiratory Distress

United States
International Centre for Diarrhoeal Disease Research...

Completed

Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71months

Hand Foot & Mouth Disease

Bangladesh
Queen Saovabha Memorial Institute

Completed

Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV

Efficacy of the New CPRV

Thailand
Jiangsu Province Centers for Disease Control and...
Bejing Vigoo Biological Co., LTD

Completed

A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months

Hand, Foot and Mouth Disease | Herpangina | Other EV71-associated Diseases

China
Sanofi Pasteur, a Sanofi Company

Completed

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults (VYF01)

Yellow Fever (Healthy Volunteers)

United States
Sonova AG
Hearts for Hearing

Completed

Optimizing Soft Speech Recognition in Children With Hearing Loss (SoftSpeech)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

United States
Sinovac Research and Development Co., Ltd.

Withdrawn

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

COVID-19

China
University of Oxford
Oxford University Hospitals NHS Trust

Unknown

Self-Help Parent Training for Conduct Problems in Children

Behavioral Symptoms

United Kingdom
Ology Bioservices

Completed

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

Influenza

United States
Ology Bioservices

Completed

Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine

Influenza | Pandemic Influenza

Austria
Ology Bioservices
Baxter Innovations GmbH

Completed

H5N1 Vaccine Study in Japanese Adults

H5N1 Influenza

Japan
Thomas Jefferson University

Completed

Toward Zero Prescribed Opioids for Outpatient General Surgery

Pain | Opioid Misuse and Addiction

United States
University of British Columbia

Withdrawn

Efficacy of Handheld Acne Heat Device

Acne Vulgaris

Canada
Ology Bioservices
Baxter Innovations GmbH

Completed

Japanese Pediatric H5N1 Vaccine Study

Influenza

Japan
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Singapore, Austria
Ology Bioservices

Completed

Yearly Strain Variation Study, 2009/2010

Influenza | Seasonal Influenza

Austria
Stemirna Therapeutics

Recruiting

New Generation mRNA Booster Vaccine Against Emerging VOCs

Efficacy | Safety | Immunogenicity

Lao People's Democratic Republic
Ology Bioservices

Completed

A/H1N1 Immunogenicity and Safety in Adults

Influenza | Pandemic Influenza

Austria, Germany
Novartis Vaccines
GlaxoSmithKline

Completed

Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

Meningococcal Meningitis | Meningoccocal Disease

Hungary, Spain
Memorial Sloan Kettering Cancer Center
PSMA Development Corp, LLC

Completed

Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel

Prostate Cancer

United States
Oslo University Hospital
Eurocine Vaccines AB; Bionor Immuno AS

Completed

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

HIV Infection

Norway
Ology Bioservices

Completed

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

Influenza

United States
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
Ohio State University
University of South Florida; New York University; National Institute on Minority... and other collaborators

Active, not recruiting

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women (A-RCT)

Depression | Anxiety | Emotional Disturbances | Nutritional Deficiency | Pregnancy Late | Post-Partum Depression

United States
Medacta International SA

Active, not recruiting

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Arthrosis | Congenital Hip Dysplasia | Traumatic Arthritis | Rheumatoid Polyarthritis | Avascular Necrosis of the Femoral Head

France

Search clinical trials for: Zero-P

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations